Our findings affirm that SLC25A28 overexpression contributes to increased weight gain and accelerates the occurrence of obesity, as mice with SLC25A28 overexpression manifested an increase in adipocyte size and serum adiponectin, while serum FGF21 decreased. Here, FGF21 is linked to obesity disorder.